Solid Biosciences盘前暴涨,一种新疗法取得良好实验效果

老虎资讯综合
18 Feb

周二,Solid Biosciences盘前暴涨超82%。此前这家基因医疗公司报告了SGT-003治疗杜氏肌营养不良症(一种遗传性肌肉疾病)的试验结果。其实验性疗法具有良好的耐受性,截至2025年2月11日,在6名患者中未出现严重不良反应事件。

Solid Biosciences预计到2025年第四季度为约20名患者服用SGT-003,并与FDA合作,寻求该药物加速获批。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10